Cargando…
吉非替尼治疗晚期非小细胞肺癌耐药后的进展模式分析
BACKGROUND AND OBJECTIVE: Clinical observation was conducted on the resistance to epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) gefitinib (Iressa) therapy for advanced non-small cell lung cancer (NSCLC) patients. METHODS: Ninety-three NSCLC patients in our hospital, showing e...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015168/ https://www.ncbi.nlm.nih.gov/pubmed/24113002 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.02 |